Orthofix Medical Q2 EPS $0.02 Beats $(0.62) Estimate, Sales $187.00M Beat $183.40M Estimate
Portfolio Pulse from Benzinga Newsdesk
Orthofix Medical (NASDAQ:OFIX) reported Q2 earnings of $0.02 per share, beating the analyst consensus estimate of $(0.62) by 103.23%. This is a 75% decrease from the same period last year. The company also reported quarterly sales of $187.00 million, beating the analyst consensus estimate of $183.40 million by 1.96%. This is a 58.38% increase from the same period last year.
August 08, 2023 | 8:15 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Orthofix Medical's Q2 earnings and sales exceeded analyst estimates, despite a decrease in earnings from the same period last year.
Orthofix Medical's Q2 earnings and sales exceeded analyst estimates, which is generally a positive signal for the stock. However, the decrease in earnings from the same period last year might temper investor enthusiasm.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100